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1. Introduction 
 
As we write this introduction in September 2014, two major ‘medical tourism’ stories have 
recently broken in the international news. First was the case of twins born to a Thai surrogate 
mother on behalf of an Australian couple. One twin was born with Down’s Syndrome and 
apparently ‘left behind’ in Thailand with his surrogate mother. Second was the case of a five-
year-old boy ‘abducted’ by his parents from a UK public (NHS) hospital and taken first to 
Spain, and then to the Czech Republic, to undergo specialist cancer treatment unavailable to 
him at home. Both cases have been extensively covered in national and international media 
(see, for example, Brierley 2014; Davies 2014; Dugan 2014; Hardy 2014; Jabour 2014; 
Meade 2104). 
 
These two cases in different ways exemplify many of the issues raised in this special issue. In 
the second, Ashya King, a young boy from the South of the UK undergoing treatment for a 
brain tumour, was reported ‘missing’ from his hospital bed -- staff alerted police that Ashya 
had been taken from the hospital without the approval of his doctors. The following day UK 
police launched a campaign on television and social media claiming that, because a battery for 
his feeding tube was due to run out, Ashya’s life was in danger. Interpol subsequently issued a 
missing persons alert and the following day a European arrest warrant was issued for parents 
Brett and Naghemeh King, based on suspicion of child neglect. Ashya later appeared with his 
father in a video posted to YouTube, in which Brett King outlined his family’s reasons for 
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their actions (YouTube 2014). Ashya’s parents were then arrested and held in jail in Spain for 
72 hours, before being released and allowed to take Ashya to the Czech Republic for 
specialist treatment. 
 
As the story developed, it transpired that the couple were seeking proton beam therapy, an 
advanced cancer treatment not yet available in the UK. While some children from the UK can 
have the therapy abroad, its public health service (the National Health Service (NHS)) paying 
treatment, flight and accommodation costs for the child and a carer in countries like the US, in 
Ashya’s case, doctors felt that conventional treatments were more appropriate. After this 
decision, relations between doctors and Ashya’s parents broke down, leaving the latter feeling 
that the only option was to ‘steal’ their son from his hospital and sell their second home to pay 
for proton beam therapy in the Czech Republic. Eventually, payment for the treatment was 
provided by the NHS via the EU directive on patient mobility, discussed below (Davies 
2014). 
 
This story raises many issues, and the role of the state in providing healthcare is central to 
them. The King family’s case is partly a question of the allocation of NHS resources and 
finances – a recurrent theme in political, media and popular debate (see, for example 
Donnelly 2014). But cost is also played off against quality of care, and with patient mobility 
and access to information about treatments abroad freely available online, the question takes 
on a transnational dimension: what does it mean for public healthcare when a new treatment is 
unavailable in the UK but is offered in the Czech Republic? 
 
In the private sector, meanwhile, business is booming. The expanding global middle classes 
are enjoined by a range of social actors to take control of their health and become 
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responsibilised citizens, managing their own health and accumulating medical knowledge 
(Connell 2011). In place of the passive patient who leaves healthcare decisions and 
responsibility to the medical authorities, citizens are being disciplined to become more active 
and engaged healthcare consumers for the sake not only of themselves but also of their 
families and of national health systems (Ormond and Sothern 2011). In Ashya’s case, the 
breakdown in the doctor-family relationship in the UK demonstrates some of the tensions 
generated by patients and their families acknowledging that a greater array of care and 
treatment possibilities may be available privately outside of their own countries. In an 
interview published in the British newspaper The Independent, Brett King explained: 
 
We pleaded with them (in Southampton) for proton beam treatment. They looked at 
me straight in the face and said with his cancer – which is called medulloblastoma – it 
would have no benefit whatsoever. I went straight back to my room and looked it up 
and the American sites and French sites and Switzerland sites where they have proton 
beam said the opposite, it would be very beneficial for him. (in Dugan 2014) 
 
Commenting on the issues raised by this case, paediatrician Joe Brierley wrote for UK 
newspaper The Guardian’s website: 
 
Patient empowerment, whether through the internet or other data sources, can be 
perceived as a mixed blessing. How do I maintain the professionalism demanded of 
me when families with ready access to a wealth of information challenge my 
recommendations? (Brierley 2014) 
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In most cases, treatment choices in the UK are based on what can be provided through the 
NHS and whatever ‘supplements’ patients and their families can afford. As wealthy Britons 
and therefore citizen-consumers with options, the Kings had a strategy. There was no proton 
beam treatment available in the UK. Treatment in the US may have been beyond their means. 
But treatment in the Czech Republic was manageable if they sold their second home. Medical 
tourism can make the unaffordable affordable, the unavailable available, but still only for 
those that can raise the funds. And whilst proton beam therapy may be reputable, albeit as yet 
not fully tested (for an interesting assessment of the treatment, see NHS Choices 2014), what 
of the other treatments available globally? Stem cell treatments to rejuvenate spinal cord 
injuries, for example? How can patient-consumers (as we might call them) decipher the 
legitimacy of their treatment choices? Information found on the internet or through word of 
mouth reflects a battleground of disputed claims and commercial interests. How should a 
patient with no medical training negotiate this interested information overload? As we shall 
see, this is a central concern for those who catch planes, trains and buses, who drive or who 
simply walk across borders each year in search of everything from the most complex to the 
most basic treatments unavailable at home.  
 
The second story that dominated the international news media in August 2014 focussed on 
transnational surrogacy. At the end of July, the Thai media broke a story about Pattaramon 
Chanbua from Chonburi province, south-east of Bangkok, who entered, via an agent, into a 
surrogacy arrangement with an Australian couple. She was paid a fee of AUD16,000, and 
gave birth to twins – a boy and a girl – in December 2013. Thailand is a medical tourism hub, 
although commercial surrogacy is technically illegal in the country. The boy twin was born 
with Down’s Syndrome and was reported as having been ‘left behind’ by his Australian 
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parents when they discovered his disability. Pattaramon, already a mother of two children, 
explained in an interview: 
 
The money that was offered was a lot for me. In my mind, with that money, one, we 
can educate my children, two, we can repay our debt. (in BBC News 2014) 
 
The motives for entering into such transactions for surrogate mothers are at first glance very 
clear. However, Patteraramon was now left holding an extra baby, Gammy as she named him, 
and one in need of significant medical treatment that beyond her means. Inevitably the story 
became more complicated. Having been named in the media on August 10, the Australian 
couple, David and Wendy Farnell, appeared on the Australian Channel Nine Network to 
present their side of the story (see Jabour 2014; Meade 2014). Gammy’s Down’s Syndrome 
had been diagnosed early on in the pregnancy, they claimed, and they had asked Pattaramon 
to abort his foetus. However, Pattaramon has refused on ethical grounds, as a Buddhist, to 
undergo an abortion, and so carried him to full term. Pattaramon said that she was scared, 
since the Australian couple (whom she never met during the surrogacy process) wanted 
Gammy aborted, that they might now harm him, leading to her decision to keep the baby. In a 
further turn, by early August more than AUD160,000 had been raised by charities to support 
Gammy’s care and his Thai family, whilst his sister, Pipah, remains under close scrutiny by 
child protection agencies in Australia. The Thai and Australian governments are both urgently 
reviewing the legal frameworks surrounding surrogacy, and transnational commercial 
surrogacy in particular.  
 
The ethical issues in the case of Gammy Chanbua seem much more stark than those raised by 
Ashya King’s. Both cases, of course, foreground the spectre of the disabled child and to what 
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extent this is viewed a tragedy, avoidable or otherwise. However, the issues raised in Ashya’s 
case seem relatively mundane compared with those of Gammy’s. Ashya’s parents suffered 
financial losses in securing expensive treatment for their son, while for Gammy’s surrogate 
mother, the AUD16,000 she was paid for having the twins as a 21 year old mother of two 
meant an investment in her children’s education and escape from debt that could mean a 
significant change in the fortunes of her family. Of course, there are many who act as 
surrogates in the West – in the UK, for instance, surrogacy is perfectly legal so long as no 
payments other than ‘expenses’ are made, typically a maximum of around GBP15,000. But 
transnational payments from high income to low income countries for embodied services – 
surrogacy, egg donation, organ transplant and so on -- take on extra significance. These two 
stories may have captured the international media spotlight, but they are part of a much bigger 
picture. 
 
 
2. Rethinking transnational healthcare 
 
What these two cases primarily tell us, then, is that the provision and regulation of healthcare 
within national boundaries is currently profoundly shifting. Growing numbers of people are 
going abroad in pursuit of healthcare, and the social, political and economic significance of 
these flows at a range of levels cannot be ignored. This special issue brings together papers 
from a key international conference held in June 2013, Transnational Healthcare: a Cross-
border Symposium – an event that was itself transnational, with hosting shared by institutions 
in two countries: first in Wageningen, The Netherlands, with delegates then travelling to 
Leeds, UK, for further presentations and discussion. The aim of this symposium was consider 
the impacts of ‘medical tourism’ in a range of different contexts, and it brought together 
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scholars involved in cutting-edge empirical and conceptual studies of the transnational pursuit 
and provision of medical care. It included findings from small-scale as well as large, multi-
site research projects. 
 
In this introduction, we outline the articles’ main themes and highlight priorities and agendas 
for the vital shared project of empirically and conceptually investigating the multi-scalar 
relational geographies -- from the macro/national to the local/embodied – that are currently 
transforming policies, economies, professions and patient experiences of what some scholars 
suggest might more appropriately be called ‘international medical travel’ (Kangas 2007) or 
‘transnational healthcare practices’ (Stan, this issue) instead of ‘medical tourism’.  
 
In recognition of the array of initiatives around the world that challenge and move beyond 
attempts at self-sufficiency in healthcare at the national level, this special issue draws 
attention to the breadth of regional capacity-building, forms of governance, relations and 
identities forged through both high-profile, long-distance pursuits of ‘medical tourists’ and 
more ‘everyday’ cross-border and intra-regional health-motivated flows (Ormond 2013b). 
The diversity of case studies presented in the special issue is intended to reflect the many 
forms of movement that together constitute transnational healthcare practices (though there 
remains much work to fully map these practices). In the remainder of this introduction, we 
draw out some of the themes and issues raised in the papers that prompt us to rethink ‘medical 
tourism’  
 
2.1. Many and multiple drivers 
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One key element in the diversity of transnational healthcare practices concerns the 
motivations of those who travel. Research to date has explored key drivers that both ‘push’ 
and ‘pull’ the various actors into crossing borders. While much of the public discussion of 
medical travel has sensationalised ‘welfare tourism’ or tended to focus on headline grabbing 
stories – either ‘human interest’, as in the cases discussed above, or ‘horror stories’ in 
frequent accounts of surgery abroad gone wrong (Connell 2011) – academic research has 
uncovered a much more variegated set of drivers, some of which are specific to the types of 
treatment accessed, some of which map onto the national healthcare and political systems of 
both sending and receiving countries, and some of which give us insight into the changing 
meanings of healthcare brought about by increasing privatisation, commercialisation and the 
forces of globalisation. In this issue, Holliday et al. (this issue) show how these different 
drivers can sometimes coalesce in a single site, as when Libyan casualties of war met British 
cosmetic surgery tourists in Tunisia. Here we see a very specific coming together of different 
healthcare movements, prompted and enabled by very different drivers: on the one hand those 
pushed violently from their own countries by internal conflict and overflowing hospitals into 
neighbouring facilities in a country with which Libya enjoys an existing cross-border 
healthcare agreement, on the other a small group of cosmetic surgery patients from the UK 
sold a ‘luxury’ package at a modest price in a tourist-friendly ‘Mediterranean’ country with 
whose broader regional political geography they are totally unfamiliar. At other times and in 
other contexts, the drivers and the routes for different travellers map divergent trajectories. 
The special issue thus contributes to the mapping of transnational healthcare mobilities at 
different scales and in different places and times. This should not be taken as meaning either 
an increasingly globally homogeneous healthcare system, or the declining importance of the 
nation-state. Rather, it is clear from the studies presented here that place and borders continue 
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to matter, and that the national scale remains of vital importance to framing how transnational 
healthcare practices take place.  
 
2.2. Beyond the atomised mobile patient 
 
While much literature to date has examined medical travel by focusing on what patients 
themselves do, believe and want, many of the articles in this collection call attention to the 
fact that individual patients are not the only ones on the move. Rather, drawing from 
assemblage theory and network analysis, several contributors have examined a range of other 
flows and ‘scapes’ (Appadurai, 1990) produced through, productive of and entwined with the 
multi-faceted phenomenon of transnational healthcare: the mobility of bodily matter (van 
Hoof et al., this issue; Lozanski, this issue); of popular, public and private regulatory 
imaginaries, such as understandings of what constitutes ‘world class’ care (Hanefeld et al, this 
issue.; Holliday et al., this issue; Whittaker & Chee, this issue); of health advocacy and social 
movements (Ormond, this issue); of medical personnel (Holliday et al., this issue; Walton-
Roberts, this issue); of medical technologies, and so on.  
 
In their study of a private Thai hospital promoting itself as ‘international’ for medical tourists, 
Whittaker and Chee (this issue) describe the coming together of patients from a variety of 
countries in a ‘cosmopolitan heterotopia’. The authors show that far from being a utopian 
exemplar of multiculturalism, cultural misunderstandings and prejudices abound -- both 
between patients and hospital staff and between different national groups of patients. The 
label ‘international’ in this case was disputed or taken by some patients to favour certain 
nationalities – Saudi Arabian or Western, for example -- over others, and such tensions 
created temporal and spatial divisions of the hospital.  
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Holliday et al. (this issue) use network, assemblage and flow theories to explore cosmetic 
surgery tourism (CST), showing how CST needs to be seen as an interplay of places, people, 
things, ideas and practices. They also chart an emerging series of ‘beautyscapes’ that, like 
CST itself, they show to be multi-scalar, transnational and ‘glocal’. The paper challenges 
‘wealthy West goes East’ narratives demonstrating the relative economic marginality of some 
western medical travellers, and also foregrounds the role of the internet in facilitating CST. 
The authors claim that this kind of medical travel would be impossible without electronic 
resources providing information on hospitals, clinics, surgeons, agents and communities of 
fellow patient-consumers. Online patient communities provide flows of intra-patient 
information and sharing of experiences, that whilst not formally recognised by the medical 
establishment prove the most reliable and accessible source for would-be travellers. 
 
Ormond (this issue) shows how perceptions of international medical travel as an atomised, 
depoliticised form of consumption are limited and how instead this form of travel can be 
reconceptualised as belonging to a range of contemporary forms of critical political 
engagement with health and social struggles within patients’ home countries and beyond. 
Through her study of Indonesians seeking care in Malaysia, she argues that medical travel can 
serve as a tool through which patients may access a host of transnational social actors who, 
together, voice concern and engage with questions of health rights, access and recognition. 
 
Studies published in this issue emphasise time and again the many roles of diverse networks, 
both formal and informal, in facilitating transnational healthcare practices. Formal 
arrangements such as bilateral agreements produce particular networks with key players 
operating as gatekeepers controlling the flows that travel along the network. Medical travel 
11 
 
agents/facilitators also have a powerful networking role, in some cases defining the pathways 
that others travel along. But informal networks, often grounded in word of mouth and local 
social contexts, are shown to be equally important. Bochaton (this issue), for example, shows 
how complicated, multi-scalar networks are drawn together to facilitate cross-border travel 
from Laos to Thailand. She also shows how members of these networks accrue and deploy 
diverse forms of capital – indeed, how participating in transnational healthcare can itself be 
capitalised upon, a point also made in Stan’s article on Romanian migrant healthcare workers. 
 
2.3. Attention to medical travellers’ source countries in the Global North and Global South 
 
Global North countries benefiting from Global South health worker ‘brain drain’ are 
increasingly called upon to assume greater responsibility and to restrict exploitative practices 
(Mackintosh et al. 2006). By contrast, when it comes to medical travel, though a growing 
body of work exists on the impacts and responsibilities of destination countries relative to the 
medical travellers they receive, scant research has examined the responsibilities of, and 
impacts on, the source countries involved (but see, e.g., Snyder et al. 2011). The articles in 
this issue by Lozanski, Ormond, and Crush and Chikanda work towards filling this gap.  
 
While commercial surrogacy practices are banned within Canada, Lozanski (this issue) 
suggests that the Canadian government’s stance on citizenship provision for children born 
from commercial surrogacy extra-territorially indicates incongruous complicity with a 
practice it has condemned on human rights grounds within its borders. Reminiscent of 
Cohen’s (2012) stance against the moral geographical pluralism advocated for by Pennings 
(2004), she argues that it is necessary to do away with this tacit complicity in order to protect 
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women outside of Canada from the oft-exploited and poorly-regulated embodied labour of 
commercial surrogacy.  
 
Crush and Chikanda (this issue) and Ormond (this issue) de-centre the dominant focus on 
medical travel from the Global North to the Global South by calling attention to the 
directionality that constitutes the bulk of medical travel flows around the world: intra-regional 
medical travel between Global South countries. With South Africa serving as a medical travel 
hub for the growing middle classes and the medically-disenfranchised poor alike from 
throughout the continent, Crush and Chikanda (this issue) note that governments in African 
source countries vary dramatically in their ability to provide quality healthcare to their 
citizens at home. Both governments and individuals throughout the broader region may turn 
to the already overburdened South African health system as an alternative provider for 
everything from the most basic to the most complex health needs. Ormond (this issue), 
meanwhile, examines the current and foreseen impacts on Indonesian politics, society and 
economics of an estimated one million Indonesians leaving their home country each year for 
medical care abroad. Studies such as these are redrawing the global map of transnational 
healthcare, challenging some of the dominant myths surrounding medical tourism and its 
effects. 
 
2.4. The supranational region as a meaningful scale in healthcare 
 
While thinking ‘regionally’ beyond national borders is well-established in economic 
development discourses and practices, studies of healthcare have long been restricted by the 
confines of ‘methodological nationalism’ (Wimmer and Glick-Schiller 2002) due to the 
history of national-level regulation and protection. Yet several recent initiatives and 
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phenomena – such as the recent European Union directive on patient mobility and growing 
cross-border patient flows facilitated by liberalised travel regimes between Association of 
Southeast Asian Nations (ASEAN) member-states – have specifically demonstrated the 
relevance of the transnational region relative to emerging post-national understandings of 
supply, demand and responsibility in healthcare.  
 
The European Union (EU), widely-known as a platform concerned with facilitating EU 
nationals’ mobility within the region, is now at least 40 years into a process of continual 
expansion of citizens’ rights with regards to patient mobility (Mainil et al. 2013). It initially 
focused on coordinating social and health policy for economic migrants and pensioners 
residing in EU countries outside their own. Temporary patient mobility, however, was only 
subject to individual jurisprudence until recently. A plethora of legal cases (e.g., Decker and 
Kohll in 1998) led the EU to develop a legal framework to enable/facilitate travel for health 
reasons within the EU, resulting in the EU Directive on Patients’ Rights in Cross-border 
Healthcare (2011/24/EU), approved after long debates and many amendments. The Directive 
enforces legal and financial relationships between source and host countries within the EU.  
 
In addition to numerous social and economic harmonisation measures, several EU instruments 
(e.g., the European Regional Development Fund (ERDF)) suggest that cross-border 
collaboration in healthcare is high on the EU agenda. However, with health systems heavily 
defined by national level regulation, scholars question the extent of actual and potential cross-
border healthcare collaboration within the EU. The articles by Volgger et al. (this issue) and 
Glinos and Baeten (this issue) offer up two diverging perspectives on this issue. Volgger et al. 
examine the western Dutch province of Zeeland bordering Belgium and the north-western 
Italian region of Tyrol bordering Austria, both areas popular with tourists but suffering from 
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declining resident populations which could result in diminishing healthcare facilities. Volgger 
et al. combine health management, system theory and tourism destination management 
principles in their study of two embryonic top-down attempts by sub-national regional 
authorities at forging cross-border regional health hubs (‘health regions’) within the European 
Union. They moot that, in offering specialised health services in these areas to 
international/European patients, it may also be possible to generate a cross-border regional 
ecosystem capable of sustaining and improving on (health) services for local cross-border 
residents. This concern with ensuring that the use of public medical infrastructure by 
foreigners does not prejudice locals’ healthcare access – and may even enhance it -- is shared 
by Lunt et al. (this issue), who cautiously and selectively embrace the entrepreneurialism 
currently unfolding within the British National Health Service’s (NHS) Trusts, where medical 
tourism is used to cross-subsidise public healthcare without burdening or undermining the 
NHS’s public service mandate. 
 
In their examination of seven examples of existing cross-border healthcare collaboration 
throughout the EU, Glinos and Baeten’s (this issue) findings contrast with Volgger et al.’s 
case studies, suggesting that the methodological nationalism underpinning the organisation of 
healthcare may prove too entrenched to overcome. Even if such collaboration is desirable, 
they argue, ‘it is not necessarily feasible. Health authorities rarely seek to structurally share 
resources across borders; in the longer term domestic solutions are usually preferred, unless 
there is another policy agenda behind’ them. They argue, however, that cross-border 
healthcare collaboration and contracting can be used strategically and creatively by local and 
national actors to ‘discipline’ domestic providers and break national monopolies at various 
scales.  
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A clear example of creative circumvention of national regulation at the micro level is 
described in van Hoof et al.’s article in this special issue on French lesbian women pursuing 
reproductive treatment across the border in Belgium, making use of variegated national moral 
stances. As the French government does not grant lesbian couples or single women the right 
to access donor sperm in France, these women are reliant upon cross-border cooperation 
between French and Belgian doctors that requires complicit French doctors to help ‘game the 
system’ in order to support the wishes of their patients.  
 
2.5. Migration and diaspora 
 
Over the last decade, much work in the domain of migration and health(care) has pointed to 
the creative-by-necessity transnational healthcare practices that migrants undertake to ensure 
access to quality care for themselves and their families (see, .e.g, Thomas and Gideon 2013; 
de Freitas and Mendes 2013). Only limited work on ‘medical tourism’ has explicitly engaged 
with this body of work so far, however (but see, e.g., Lee et al. 2010; Ormond 2013a). Rather, 
most research has to date conceptualised their object of study as little more than a discrete 
episode measured in days, weeks and perhaps months in which patients unproblematically 
leave their home countries, go abroad to receive care in countries in which they have a legal 
right to enter and stay for a set period of time, and then return to their home countries and 
resume their daily lives. However, several of the studies featured in this issue suggest that 
medical travel -- when facilitated by political arrangements and transport options -- can also 
be far more pendular, characterised by participation in multiple national health systems 
simultaneously and potentially frequent cross-border commuting. 
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The articles in this collection by Stan and Hanefeld et al. draw our attention to the 
significance of the politico-legal status of the travelling subjects themselves in both the source 
and receiving countries. Some EU member-states’ governments and health systems have 
grown increasingly wary of potentially unmanageable inbound foreign patient flows, resulting 
in attempts to clamp down on ‘welfare tourists’ and NHS ‘abusers’ in the UK (Vargas-Silva 
and McNeil 2014), and in the Spanish government initially balking at the introduction of the 
EU patient directive (Villanueva 2010). Stan’s study of Romanian migrants in Ireland points 
to the uneven mobility and employment rights of Romanians within the EU. Groups within 
Ireland, like the UK, fear and seek to curtail potential ‘abuse’ of public services like 
healthcare and education by poorer intra-regional migrants from Eastern Europe. The popular 
static and exaggerated portrayal of intra-regional migrants as burdens on host country health 
systems is shown to be unfounded. Stan notes that the migrants in her study ‘have been quick 
to use their feet to defy any simplified image of a stable, and encroaching, migrant 
population’.  
 
This is further demonstrated in Hanefeld et al.’s (this issue) study of UK residents travelling 
abroad for healthcare. Hanefeld et al. chose to not simply focus on people of British origin but 
also on migrants and members of diasporic groups settled in the UK. They noted that those in 
their sample of Somali and Indian origin were more familiar with, and thus better able to 
compare, the UK’s public and private health system with those in their countries of origin as 
well as third countries in which they had studied or lived previously. The role of comparative 
knowledge in opting for medical care outside of one’s country of residence speaks to our 
increasing hyper-mobility. These two articles call attention to the rationales for healthcare 
choices by the non-negligible numbers of people who have not only experienced a range of 
health systems but may also be living away from the systems with which they are most 
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comfortable, be they economic migrants, refugees, international students, expatriates, 
retirement migrants, etc. Both articles underscore the urgency of acknowledging the diversity 
and nuances of migration temporalities, employment statuses and integration trajectories and 
how these impact on migrants’ engagements in (transnational) healthcare practices. 
 
The articles by Bochaton (this issue) and Walton-Roberts (this issue) furthermore point to the 
significance of diasporic groups not only as patients but also as transnational healthcare 
facilitators, mediators and investors. Walton-Roberts highlights the role of Non-Resident 
Indian (NRI) investment and ‘brain-circulation’ of Indian doctors and administrators in the 
internationalisation of hospitals and medical education in India. Bochaton meanwhile shows 
how diasporic networks influence Laotians’ pursuits of healthcare in Thailand, by offering 
advice based on their experiences with health systems in more developed countries and 
treatment funding via remittances. These examples demonstrate the range of formal and 
informal transnational care networks on which medical travellers may draw. 
 
2.6. Care work and embodied labour 
 
Several articles in this special issue call attention to the underexamined role and dimensions 
of formal and informal care work involved in international medical travel. Much research to 
date has drawn on the General Agreement on Trade in Services (GATS) as a way to 
demonstrate how international medical travel or ‘medical tourism’ fits within broader 
mobility and trade in services frameworks. However, there has been limited engagement with 
literature on health worker migration, with only a few studies showing the nexus between 
patients and health workers travelling abroad or other emerging transnational healthcare 
practices such as telemedicine (see, e.g., Whittaker 2008; Connell 2011). 
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The papers in this collection by Walton-Roberts, Lozanski, and Whittaker and Chee all bring 
to light novel ways of engaging with the variety of care workers that medical travellers 
encounter. Walton-Roberts (this issue) embeds the shifts in quality and costs of Indian nursing 
education within the context of globalised market demands that draw many Indian nurses 
abroad and/or to care for foreign medical travellers within India’s growing number of private 
hospitals, diasporic investment in private healthcare and education, and brain-circulation at 
the managerial level that internationalises policies and development agendas. In their study of 
one private Thai hospital renowned for medical tourism, Whittaker and Chee (this issue) 
describe the culturally-shaped power relations among Thai nurses and orderlies as well as the 
incongruous expectations and behaviours that result in friction and dissonance between non-
Asian foreign patients and these same Thai hospital caregivers. Lozanski (this issue), on the 
other hand, draws attention to the ways in which commercial surrogates’ embodied labour is 
exploited by transnational surrogacy companies. This exploitation is in turn met with tacit 
approval by some intended parents’ national governments that acknowledge the citizenship 
rights of children produced through commercial surrogacy. These articles point to the need to 
develop future research that engages with the growing literature on global care chains (GCC) 
as well as on forms of labour in the tourism industry (Gibson 2009) and in healthcare (Mol 
2002).  
 
 
3. Conclusions 
 
The articles collected here provide us with empirical, methodological and conceptual tools for 
the ongoing task of mapping transnational healthcare practices. Moving beyond the clumsy 
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catch-all phrase ‘medical tourism’ – with all its attendant baggage – we have assembled 
accounts of very particular practices that lead certain people to decide to cross national 
borders to access healthcare. It should be apparent from reading the papers that there is no 
simple accounting for this situation, nor for understanding travellers’ motives and experiences 
and the impacts on the different (levels of) health systems involved. The papers show the 
importance of attention to detail and context, and for listening to accounts ‘on the ground’ that 
can then provide the basis for theorising. We set out in the call for papers for the symposium a 
challenge to define an emerging field, and to exemplify its key concerns. The papers selected 
for inclusion in this special issue have met that challenge -- in fact, they have well exceeded 
it. Taken together, they highlight the vital importance of closely following what is sure to be 
an evolving and expanding field. They show that multi-scalar, multi-disciplinary approaches 
are necessary, combined with deep immersion in the particularities of practices, whether these 
are enacted by healthcare workers, tourism workers, patients, families, care-givers, or by and 
through networks (both formal and informal) that draw together many different actors. We 
began this introduction with two very different, very particular accounts that show the 
complexities often lost in generalised discussion of ‘medical tourism’. We look forward to 
reading further accounts that continue the work we have contributed to in this issue of Social 
Science & Medicine. 
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